Nonalcoholic fatty liver disease (NAFLD) is a dynamic chronic liver disease that develops in
close association with metabolic irregularities. Between 2016 and 2019, the global …

Non-alcoholic fatty liver disease (NAFLD) is a significant public health concern worldwide
with a complex etiology attributed to behavioural, environmental, and genetic causes. The …

Innovative non-pharmacological lifestyle strategies to treat non-alcoholic fatty liver disease
(NAFLD) are critically needed. This study compared the effects of alternate day fasting (ADF) …

Conclusions: The panel found consistent and compelling evidence that regular physical
activity plays an important role in preventing NAFLD and improving intermediate clinical …

Different dietary regimens for weight loss have developed over the years. Since the most
evidenced treatment for non‐alcoholic fatty liver disease (NAFLD) is weight reduction, it is …

Metabolic-dysfunction-associated steatotic liver disease (MASLD) is a chronic liver disease
that affects more than a quarter of the global population and whose prevalence is increasing …

Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …

METHODS: Randomized controlled trials in adults with NAFLD were identified through
March 2022. Exercise training was compared to no exercise training. The primary outcome …

Nonalcoholic fatty liver disease (NAFLD) is a prevalent condition among postmenopausal
women that can lead to severe liver dysfunction and increased mortality. In recent years …

Weight loss achieved through a combination of healthy eating patterns that encompass the
principles of the Mediterranean diet and regular physical activity is the most evidence-based …